Delivery Order SPE2D021D0005-SPE2D025F0397
Award Date
5/14/25
Potential Completion Date
6/22/26
Potential Value
$872K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of oseltamivir phosphate (Tamiflu), an antiviral medication. The $141,052.05 firm-fixed-price delivery order is not associated with any set-aside designation. Genentech holds several established contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule with the Department of Veterans Affairs to...
This federal contract award, SPE2DP16D0008|0051, was issued by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology and pharmaceutical manufacturer. The $76,496.94 firm-fixed-price delivery order is for the supply of oseltamivir phosphate, an antiviral medication, with a period of performance through September 11, 2018. Genentech holds several major contract vehicles with federal agencies like the Department of Veterans Affairs and the Department...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of oseltamivir phosphate, an antiviral medication, with a ceiling value of $85,938.87. The contract has a firm fixed price and does not utilize any set-aside designations. Genentech has several existing contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule...
The Defense Logistics Agency Troop Support Medical awarded a $116,303.04 delivery order contract to Genentech USA, Inc. for the antiviral medication oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of pharmaceuticals that has held numerous indefinite delivery contracts and blanket purchase agreements with various federal agencies for critical biologic medicines. This contract does not utilize any set-asides and will be performed at Genentech's facility in South San...
This is a $159,762.84 delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc. for the supply of the antiviral medication oseltamivir phosphate. The contract has a firm fixed price and a completion date of September 11, 2018. Genentech USA, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products, and this order was likely issued against an existing indefinite delivery contract or Federal Supply Schedule to support the...
This is a $398,047.11 delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor Genentech USA, Inc. The contract provides for the delivery of other medical supplies, with a performance location in South San Francisco, California. Genentech is a foreign-owned, for-profit organization that manufactures pharmaceutical products. The contract does not utilize a set-aside designation. Genentech holds multiple indefinite delivery and Federal Supply...
This federal contract award to Genentech USA, Inc., a foreign-owned, for-profit biotechnology manufacturer, is a delivery order under the Department of Veterans Affairs' $4.9 billion Federal Supply Schedule 61-IB for pharmaceuticals and drugs. The $60,000,000 contract provides a vehicle for the Office of the Assistant Secretary for Preparedness and Response (ASPR) to procure products needed to support the Division of Strategic National Stockpile. The award does not utilize a set-aside...
This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals. The $115,283.85 firm fixed-price contract is for the antiviral medication oseltamivir phosphate, with a completion date of August 2, 2023. Genentech, which has provided various drugs to federal agencies through indefinite delivery contracts and Federal Supply Schedule agreements, will perform the work at its facility in...
Genentech USA, Inc. was awarded a $6,511.32 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 50 milligram vials of ActiVase with diluent for injection. The firm fixed price order calls for Genentech to deliver the pharmaceutical products to a location in South San Francisco, California between October 19 and October 22, 2021. No set aside designation or subcontractors were identified. The Defense Logistics...
The Defense Logistics Agency Troop Support Medical awarded an $690,616 delivery order to Genentech USA, Inc. of South San Francisco, California under contract number 8507376885 for other medical products and services. The firm fixed price order has a period of performance from May 15, 2020 to June 30, 2021 for products and services to be delivered to South San Francisco. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports Department of Defense health...